 | • レポートコード：D0GIR-02885 • 出版社/出版日：GlobalInfoResearch / 2020年9月30日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、103ページ • 納品方法：Eメール • 産業分類：医療、製薬、バイオ |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、β-ラクタム系抗生剤の世界市場を広く調査・分析し、今後の市場展望をまとめております。β-ラクタム系抗生剤の種類別市場規模（ペニシリン、セファロスポリン、カルバペネム、単菌）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：GlaxoSmithKline plc、Merck & Co., Inc.、Pfizer, Inc.、AstraZeneca plc、Shionogi & Co., Ltd.、Eli Lilly and Company ・地域別グローバル市場分析 2015年-2020年 ・β-ラクタム系抗生剤の北米市場（アメリカ、カナダ、メキシコ） ・β-ラクタム系抗生剤のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・β-ラクタム系抗生剤のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・β-ラクタム系抗生剤の南米市場（ブラジル、アルゼンチン） ・β-ラクタム系抗生剤の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：ペニシリン、セファロスポリン、カルバペネム、単菌 ・用途別分析：病院薬局、小売薬局、オンライン薬局 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The Beta-Lactam Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The most likely (base case) scenario is that the global Beta-Lactam Drugs sales will be xx in 2020 from Beta-Lactam Drugs million in 2019, with a change xx% between 2019 and 2020. In addition, based on the latest study, it is to predict that the Covid-19 will be under control in key countries like the United States, Western Europe, East Asia, by the end of Q2 (June), and will resume normal production in Q3 and Q4, the global Beta-Lactam Drugs market size is expected to grow at xx% or more annually for the next five years.
This report also researches and evaluates the impact of Covid-19 outbreak on the Beta-Lactam Drugs industry, involving potential opportunity and challenges, drivers and risks. We present the impact assessment of Covid-19 effects on Beta-Lactam Drugs and market growth forecast based on different scenario (optimistic, pessimistic, very optimistic, most likely etc.).
Market segmentation
Beta-Lactam Drugs market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Beta-Lactam Drugs market has been segmented into:
Penicillin
Cephalosporins
Carbapenem
Monobacteria
By Application, Beta-Lactam Drugs has been segmented into:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Beta-Lactam Drugs market presented in the report. This section sheds light on the sales growth of different regional and country-level Beta-Lactam Drugs markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Beta-Lactam Drugs market.
The report offers in-depth assessment of the growth and other aspects of the Beta-Lactam Drugs market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Beta-Lactam Drugs Market Share Analysis
Beta-Lactam Drugs competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Beta-Lactam Drugs sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Beta-Lactam Drugs sales, revenue and market share for each player covered in this report.
The major players covered in Beta-Lactam Drugs are:
GlaxoSmithKline plc
Merck & Co., Inc.
Pfizer, Inc.
AstraZeneca plc
Shionogi & Co., Ltd.
Eli Lilly and Company
Among other players domestic and global, Beta-Lactam Drugs market share data is available for global, North America, Europe, Asia-Pacific, Middle East & Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
1 Beta-Lactam Drugs Market Overview
1.1 Product Overview and Scope of Beta-Lactam Drugs
1.2 Classification of Beta-Lactam Drugs by Type
1.2.1 Global Beta-Lactam Drugs Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Beta-Lactam Drugs Revenue Market Share by Type in 2019
1.2.3 Penicillin
1.2.4 Cephalosporins
1.2.5 Carbapenem
1.2.6 Monobacteria
1.3 Global Beta-Lactam Drugs Market by Application
1.3.1 Overview: Global Beta-Lactam Drugs Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Global Beta-Lactam Drugs Market by Regions
1.4.1 Global Beta-Lactam Drugs Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Beta-Lactam Drugs (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Beta-Lactam Drugs Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Beta-Lactam Drugs Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Beta-Lactam Drugs Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Beta-Lactam Drugs Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Beta-Lactam Drugs Status and Prospect (2015-2025)
1.5 COVID-19 Outbreak: Beta-Lactam Drugs Industry Impact
1.5.1 COVID-19 Potential Implications for the Beta-Lactam Drugs
1.5.1.1 Scenario One: Very Optimistic: COVID-19 has No Influence on Beta-Lactam Drugs
1.5.1.2 Scenario Two: Optimistic: COVID-19 Will Be Under Control by the End of April
1.5.1.3 Scenario Three: Gloomy: COVID-19 Will Be Under Control Between Q3 and Q4
1.5.1.4 Scenario Four: Most Likely: COVID-19 Will Be Under Control by the End of Q2
1.5.2 Opportunity Analysis in Covid-19 Crisis
1.5.3 Market Risk and Restraints
1.5.4 Market Driving Force
2 Company Profiles
2.1 GlaxoSmithKline plc
2.1.1 GlaxoSmithKline plc Details
2.1.2 GlaxoSmithKline plc Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 GlaxoSmithKline plc SWOT Analysis
2.1.4 GlaxoSmithKline plc Product and Services
2.1.5 GlaxoSmithKline plc Beta-Lactam Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.2 Merck & Co., Inc.
2.2.1 Merck & Co., Inc. Details
2.2.2 Merck & Co., Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Merck & Co., Inc. SWOT Analysis
2.2.4 Merck & Co., Inc. Product and Services
2.2.5 Merck & Co., Inc. Beta-Lactam Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.3 Pfizer, Inc.
2.3.1 Pfizer, Inc. Details
2.3.2 Pfizer, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Pfizer, Inc. SWOT Analysis
2.3.4 Pfizer, Inc. Product and Services
2.3.5 Pfizer, Inc. Beta-Lactam Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.4 AstraZeneca plc
2.4.1 AstraZeneca plc Details
2.4.2 AstraZeneca plc Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 AstraZeneca plc SWOT Analysis
2.4.4 AstraZeneca plc Product and Services
2.4.5 AstraZeneca plc Beta-Lactam Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.5 Shionogi & Co., Ltd.
2.5.1 Shionogi & Co., Ltd. Details
2.5.2 Shionogi & Co., Ltd. Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Shionogi & Co., Ltd. SWOT Analysis
2.5.4 Shionogi & Co., Ltd. Product and Services
2.5.5 Shionogi & Co., Ltd. Beta-Lactam Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.6 Eli Lilly and Company
2.6.1 Eli Lilly and Company Details
2.6.2 Eli Lilly and Company Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Eli Lilly and Company SWOT Analysis
2.6.4 Eli Lilly and Company Product and Services
2.6.5 Eli Lilly and Company Beta-Lactam Drugs Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Beta-Lactam Drugs Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Beta-Lactam Drugs Players Market Share
3.2.2 Top 10 Beta-Lactam Drugs Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Beta-Lactam Drugs Revenue and Market Share by Regions
4.2 North America Beta-Lactam Drugs Revenue and Growth Rate (2015-2020)
4.3 Europe Beta-Lactam Drugs Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Beta-Lactam Drugs Revenue and Growth Rate (2015-2020)
4.5 South America Beta-Lactam Drugs Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Beta-Lactam Drugs Revenue and Growth Rate (2015-2020)
5 North America Beta-Lactam Drugs Revenue by Countries
5.1 North America Beta-Lactam Drugs Revenue by Countries (2015-2020)
5.2 USA Beta-Lactam Drugs Revenue and Growth Rate (2015-2020)
5.3 Canada Beta-Lactam Drugs Revenue and Growth Rate (2015-2020)
5.4 Mexico Beta-Lactam Drugs Revenue and Growth Rate (2015-2020)
6 Europe Beta-Lactam Drugs Revenue by Countries
6.1 Europe Beta-Lactam Drugs Revenue by Countries (2015-2020)
6.2 Germany Beta-Lactam Drugs Revenue and Growth Rate (2015-2020)
6.3 UK Beta-Lactam Drugs Revenue and Growth Rate (2015-2020)
6.4 France Beta-Lactam Drugs Revenue and Growth Rate (2015-2020)
6.5 Russia Beta-Lactam Drugs Revenue and Growth Rate (2015-2020)
6.6 Italy Beta-Lactam Drugs Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Beta-Lactam Drugs Revenue by Countries
7.1 Asia-Pacific Beta-Lactam Drugs Revenue by Countries (2015-2020)
7.2 China Beta-Lactam Drugs Revenue and Growth Rate (2015-2020)
7.3 Japan Beta-Lactam Drugs Revenue and Growth Rate (2015-2020)
7.4 Korea Beta-Lactam Drugs Revenue and Growth Rate (2015-2020)
7.5 India Beta-Lactam Drugs Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Beta-Lactam Drugs Revenue and Growth Rate (2015-2020)
8 South America Beta-Lactam Drugs Revenue by Countries
8.1 South America Beta-Lactam Drugs Revenue by Countries (2015-2020)
8.2 Brazil Beta-Lactam Drugs Revenue and Growth Rate (2015-2020)
8.3 Argentina Beta-Lactam Drugs Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Beta-Lactam Drugs by Countries
9.1 Middle East & Africa Beta-Lactam Drugs Revenue by Countries (2015-2020)
9.2 Saudi Arabia Beta-Lactam Drugs Revenue and Growth Rate (2015-2020)
9.3 UAE Beta-Lactam Drugs Revenue and Growth Rate (2015-2020)
9.4 Egypt Beta-Lactam Drugs Revenue and Growth Rate (2015-2020)
9.5 South Africa Beta-Lactam Drugs Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Beta-Lactam Drugs Revenue and Market Share by Type (2015-2020)
10.2 Global Beta-Lactam Drugs Market Forecast by Type (2019-2024)
10.3 Penicillin Revenue Growth Rate (2015-2025)
10.4 Cephalosporins Revenue Growth Rate (2015-2025)
10.5 Carbapenem Revenue Growth Rate (2015-2025)
10.6 Monobacteria Revenue Growth Rate (2015-2025)
11 Global Beta-Lactam Drugs Market Segment by Application
11.1 Global Beta-Lactam Drugs Revenue Market Share by Application (2015-2020)
11.2 Beta-Lactam Drugs Market Forecast by Application (2019-2024)
11.3 Hospital Pharmacies Revenue Growth (2015-2020)
11.4 Retail Pharmacies Revenue Growth (2015-2020)
11.5 Online Pharmacies Revenue Growth (2015-2020)
12 Global Beta-Lactam Drugs Market Size Forecast (2021-2025)
12.1 Global Beta-Lactam Drugs Market Size Forecast (2021-2025)
12.2 Global Beta-Lactam Drugs Market Forecast by Regions (2021-2025)
12.3 North America Beta-Lactam Drugs Revenue Market Forecast (2021-2025)
12.4 Europe Beta-Lactam Drugs Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Beta-Lactam Drugs Revenue Market Forecast (2021-2025)
12.6 South America Beta-Lactam Drugs Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Beta-Lactam Drugs Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Beta-Lactam Drugs Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Beta-Lactam Drugs by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Beta-Lactam Drugs Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Beta-Lactam Drugs Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Global Beta-Lactam Drugs Market Size and Growth Estimation in Various Scenarios in 2020
Table 6. GlaxoSmithKline plc Corporate Information, Location and Competitors
Table 7. GlaxoSmithKline plc Beta-Lactam Drugs Major Business
Table 8. GlaxoSmithKline plc Beta-Lactam Drugs Total Revenue (USD Million) (2017-2018)
Table 9. GlaxoSmithKline plc SWOT Analysis
Table 10. GlaxoSmithKline plc Beta-Lactam Drugs Product and Solutions
Table 11. GlaxoSmithKline plc Beta-Lactam Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 12. Merck & Co., Inc. Corporate Information, Location and Competitors
Table 13. Merck & Co., Inc. Beta-Lactam Drugs Major Business
Table 14. Merck & Co., Inc. Beta-Lactam Drugs Total Revenue (USD Million) (2018-2019)
Table 15. Merck & Co., Inc. SWOT Analysis
Table 16. Merck & Co., Inc. Beta-Lactam Drugs Product and Solutions
Table 17. Merck & Co., Inc. Beta-Lactam Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 18. Pfizer, Inc. Corporate Information, Location and Competitors
Table 19. Pfizer, Inc. Beta-Lactam Drugs Major Business
Table 20. Pfizer, Inc. Beta-Lactam Drugs Total Revenue (USD Million) (2017-2018)
Table 21. Pfizer, Inc. SWOT Analysis
Table 22. Pfizer, Inc. Beta-Lactam Drugs Product and Solutions
Table 23. Pfizer, Inc. Beta-Lactam Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 24. AstraZeneca plc Corporate Information, Location and Competitors
Table 25. AstraZeneca plc Beta-Lactam Drugs Major Business
Table 26. AstraZeneca plc Beta-Lactam Drugs Total Revenue (USD Million) (2017-2018)
Table 27. AstraZeneca plc SWOT Analysis
Table 28. AstraZeneca plc Beta-Lactam Drugs Product and Solutions
Table 29. AstraZeneca plc Beta-Lactam Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 30. Shionogi & Co., Ltd. Corporate Information, Location and Competitors
Table 31. Shionogi & Co., Ltd. Beta-Lactam Drugs Major Business
Table 32. Shionogi & Co., Ltd. Beta-Lactam Drugs Total Revenue (USD Million) (2017-2018)
Table 33. Shionogi & Co., Ltd. SWOT Analysis
Table 34. Shionogi & Co., Ltd. Beta-Lactam Drugs Product and Solutions
Table 35. Shionogi & Co., Ltd. Beta-Lactam Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 36. Eli Lilly and Company Corporate Information, Location and Competitors
Table 37. Eli Lilly and Company Beta-Lactam Drugs Major Business
Table 38. Eli Lilly and Company Beta-Lactam Drugs Total Revenue (USD Million) (2017-2018)
Table 39. Eli Lilly and Company SWOT Analysis
Table 40. Eli Lilly and Company Beta-Lactam Drugs Product and Solutions
Table 41. Eli Lilly and Company Beta-Lactam Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 42. Global Beta-Lactam Drugs Revenue (Million USD) by Players (2015-2020)
Table 43. Global Beta-Lactam Drugs Revenue Share by Players (2015-2020)
Table 44. Global Beta-Lactam Drugs Revenue (Million USD) by Regions (2015-2020)
Table 45. Global Beta-Lactam Drugs Revenue Market Share by Regions (2015-2020)
Table 46. North America Beta-Lactam Drugs Revenue by Countries (2015-2020)
Table 47. North America Beta-Lactam Drugs Revenue Market Share by Countries (2015-2020)
Table 48. Europe Beta-Lactam Drugs Revenue (Million USD) by Countries (2015-2020)
Table 49. Asia-Pacific Beta-Lactam Drugs Revenue (Million USD) by Countries (2015-2020)
Table 50. South America Beta-Lactam Drugs Revenue by Countries (2015-2020)
Table 51. South America Beta-Lactam Drugs Revenue Market Share by Countries (2015-2020)
Table 52. Middle East and Africa Beta-Lactam Drugs Revenue (Million USD) by Countries (2015-2020)
Table 53. Middle East and Africa Beta-Lactam Drugs Revenue Market Share by Countries (2015-2020)
Table 54. Global Beta-Lactam Drugs Revenue (Million USD) by Type (2015-2020)
Table 55. Global Beta-Lactam Drugs Revenue Share by Type (2015-2020)
Table 56. Global Beta-Lactam Drugs Revenue Forecast by Type (2021-2025)
Table 57. Global Beta-Lactam Drugs Revenue by Application (2015-2020)
Table 58. Global Beta-Lactam Drugs Revenue Share by Application (2015-2020)
Table 59. Global Beta-Lactam Drugs Revenue Forecast by Application (2021-2025)
Table 60. Global Beta-Lactam Drugs Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Beta-Lactam Drugs Picture
Figure 2. Global Beta-Lactam Drugs Revenue Market Share by Type in 2019
Figure 3. Penicillin Picture
Figure 4. Cephalosporins Picture
Figure 5. Carbapenem Picture
Figure 6. Monobacteria Picture
Figure 7. Beta-Lactam Drugs Revenue Market Share by Application in 2019
Figure 8. Hospital Pharmacies Picture
Figure 9. Retail Pharmacies Picture
Figure 10. Online Pharmacies Picture
Figure 11. Global Beta-Lactam Drugs Revenue (USD Million) and Growth Rate (2015-2025)
Figure 12. North America Beta-Lactam Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Europe Beta-Lactam Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Asia-Pacific Beta-Lactam Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. South America Beta-Lactam Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Middle East and Africa Beta-Lactam Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global Beta-Lactam Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global Beta-Lactam Drugs Revenue Share by Players in 2019
Figure 19. Global Top 5 Players Beta-Lactam Drugs Revenue Market Share in 2019
Figure 20. Global Top 10 Players Beta-Lactam Drugs Revenue Market Share in 2019
Figure 21. Key Players Market Share Trend
Figure 22. Global Beta-Lactam Drugs Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 23. Global Beta-Lactam Drugs Revenue Market Share by Regions (2015-2020)
Figure 24. Global Beta-Lactam Drugs Revenue Market Share by Regions in 2018
Figure 25. North America Beta-Lactam Drugs Revenue and Growth Rate (2015-2020)
Figure 26. Europe Beta-Lactam Drugs Revenue and Growth Rate (2015-2020)
Figure 27. Asia-Pacific Beta-Lactam Drugs Revenue and Growth Rate (2015-2020)
Figure 28. South America Beta-Lactam Drugs Revenue and Growth Rate (2015-2020)
Figure 29. Middle East and Africa Beta-Lactam Drugs Revenue and Growth Rate (2015-2020)
Figure 30. North America Beta-Lactam Drugs Revenue Market Share by Countries (2015-2020)
Figure 31. North America Beta-Lactam Drugs Revenue Market Share by Countries in 2019
Figure 32. USA Beta-Lactam Drugs Revenue and Growth Rate (2015-2020)
Figure 33. Canada Beta-Lactam Drugs Revenue and Growth Rate (2015-2020)
Figure 34. Mexico Beta-Lactam Drugs Revenue and Growth Rate (2015-2020)
Figure 35. Europe Beta-Lactam Drugs Revenue Market Share by Countries (2015-2020)
Figure 36. Europe Beta-Lactam Drugs Revenue Market Share by Countries in 2019
Figure 37. Germany Beta-Lactam Drugs Revenue and Growth Rate (2015-2020)
Figure 38. UK Beta-Lactam Drugs Revenue and Growth Rate (2015-2020)
Figure 39. France Beta-Lactam Drugs Revenue and Growth Rate (2015-2020)
Figure 40. Russia Beta-Lactam Drugs Revenue and Growth Rate (2015-2020)
Figure 41. Italy Beta-Lactam Drugs Revenue and Growth Rate (2015-2020)
Figure 42. Asia-Pacific Beta-Lactam Drugs Revenue Market Share by Countries (2015-2020)
Figure 43. Asia-Pacific Beta-Lactam Drugs Revenue Market Share by Countries in 2019
Figure 44. China Beta-Lactam Drugs Revenue and Growth Rate (2015-2020)
Figure 45. Japan Beta-Lactam Drugs Revenue and Growth Rate (2015-2020)
Figure 46. Korea Beta-Lactam Drugs Revenue and Growth Rate (2015-2020)
Figure 47. India Beta-Lactam Drugs Revenue and Growth Rate (2015-2020)
Figure 48. Southeast Asia Beta-Lactam Drugs Revenue and Growth Rate (2015-2020)
Figure 49. South America Beta-Lactam Drugs Revenue Market Share by Countries (2015-2020)
Figure 50. South America Beta-Lactam Drugs Revenue Market Share by Countries in 2019
Figure 51. Brazil Beta-Lactam Drugs Revenue and Growth Rate (2015-2020)
Figure 52. Argentina Beta-Lactam Drugs Revenue and Growth Rate (2015-2020)
Figure 53. Middle East and Africa Beta-Lactam Drugs Revenue Market Share by Countries (2015-2020)
Figure 54. Middle East and Africa Beta-Lactam Drugs Revenue Market Share by Countries in 2019
Figure 55. Saudi Arabia Beta-Lactam Drugs Revenue and Growth Rate (2015-2020)
Figure 56. UAE Beta-Lactam Drugs Revenue and Growth Rate (2015-2020)
Figure 57. Egypt Beta-Lactam Drugs Revenue and Growth Rate (2015-2020)
Figure 58. South Africa Beta-Lactam Drugs Revenue and Growth Rate (2015-2020)
Figure 59. Global Beta-Lactam Drugs Revenue Share by Type (2015-2020)
Figure 60. Global Beta-Lactam Drugs Revenue Share by Type in 2019
Figure 61. Global Beta-Lactam Drugs Market Share Forecast by Type (2021-2025)
Figure 62. Global Penicillin Revenue Growth Rate (2015-2020)
Figure 63. Global Cephalosporins Revenue Growth Rate (2015-2020)
Figure 64. Global Carbapenem Revenue Growth Rate (2015-2020)
Figure 65. Global Monobacteria Revenue Growth Rate (2015-2020)
Figure 66. Global Beta-Lactam Drugs Revenue Share by Application (2015-2020)
Figure 67. Global Beta-Lactam Drugs Revenue Share by Application in 2019
Figure 68. Global Beta-Lactam Drugs Market Share Forecast by Application (2021-2025)
Figure 69. Global Hospital Pharmacies Revenue Growth Rate (2015-2020)
Figure 70. Global Retail Pharmacies Revenue Growth Rate (2015-2020)
Figure 71. Global Online Pharmacies Revenue Growth Rate (2015-2020)
Figure 72. Global Beta-Lactam Drugs Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 73. Global Beta-Lactam Drugs Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 74. Global Beta-Lactam Drugs Revenue Market Share Forecast by Regions (2021-2025)
Figure 75. North America Beta-Lactam Drugs Revenue Market Forecast (2021-2025)
Figure 76. Europe Beta-Lactam Drugs Revenue Market Forecast (2021-2025)
Figure 77. Asia-Pacific Beta-Lactam Drugs Revenue Market Forecast (2021-2025)
Figure 78. South America Beta-Lactam Drugs Revenue Market Forecast (2021-2025)
Figure 79. Middle East and Africa Beta-Lactam Drugs Revenue Market Forecast (2021-2025)
Figure 80. Sales Channel: Direct Channel vs Indirect Channel
抗生物質薬の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Antibiotics Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Antibiotics Drugs market re…- ヒトインテグリンベータ3の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The Human Integrin Beta 3 market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization,…
- 狭心症治療薬の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Angina Pectoris Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 5.2% in the forecast period of 2020 to 2025 and will expected to reach USD 10860 million by 2025, from USD 8865.7 million in 2019. The Angina Pectoris…
- β-グルカンの世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Beta Glucan market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Beta Glucan market report provide…
- 矯正用ベータチタンアーチワイヤーの世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The Beta Titanium Orthodontic Archwire market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain …